Skip to Main Content

Paper Details

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.
Mol Oncol
8
2022
-, DNA methyltransferase, DNMT, ERG, ETS transcription factor, HDAC, Prostate cancer, SNAI2, TMPRSS2, cancer, dasatinib, histone deacetylase, panobinostat, prostate cancer, serine, snail family transcriptional repressor 2, transmembrane serine protease 2, tumor, tumor cell, tumor stroma
Author NameAffiliation
Martin Sj??str??mUniversity of California San Francisco
Martin Sj??str??mUniversity of California San Francisco
Travis GerkeProstate Cancer Clinical Trials Consortium
Travis GerkeProstate Cancer Clinical Trials Consortium
Lorelei A MucciHarvard T.H. Chan School of Public Health
Felix Y FengUniversity of California San Francisco
Felix Y FengUniversity of California San Francisco
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
Felix Y FengUniversity of California San Francisco
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
  • 1 - 11

Datasets

Release 1.2